Note that DOK7 gene therapy did not affect degeneration of motor neuron cell bodies even at end stage (P150) in ALS mice (Fig EV4A and B), implying that the protective effect of this therapy may be confined distally at the NMJ. This evidence concerns the gene DOK7 and amyotrophic lateral sclerosis.